ALB and Sepsis: In the ALBIOS study, conducted in 100 ICUs in Italy [62], 1,818 patients with severe sepsis or septic shock were randomized either to receive 300 ml of 20% albumin plus crystalloid or to receive crystalloid alone initially to achieve the target resuscitation goals of the early goal-directed therapy protocol used by Rivers and colleagues [73].